[1] |
Kimura Y, Takada T, Kawarada Y, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo guidelines[J]. J Hepatobiliary Pancreat Surg, 2007, 14(1):15-26.
|
[2] |
Beliaev AM, Zyul'korneeva S, Rowbotham D, et al. Screening acute cholangitis patients for sepsis[J]. ANZ J Surg, 2019, 89(11):1457-1461.
|
[3] |
罗德惠, 万翔, 刘际明, 等. 如何实现从样本量、中位数、极值或四分位数到均数与标准差的转换[J]. 中国循证医学杂志, 2017, 17(11):1350-1356.
|
[4] |
Shinya S, Sasaki T, Yamashita Y, et al. Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis[J]. J Hepato Biliary Pancreat, 2014, 21(10):777-785.
|
[5] |
Suwa Y, Matsuyama R, Goto K, et al. IL-7 and procalcitonin are useful biomarkers in the comprehensive evaluation of the severity of acute cholangitis[J]. J Hepato Biliary Pancreat, 2017, 24(2):81-88.
|
[6] |
Umefune G, Kogure H, Hamada T, et al. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study[J]. J Gastroenterol, 2017, 52(6):734-745.
|
[7] |
范迪欢, 邬善敏. 血清降钙素原对急性胆管炎病情早期诊断及预后评估的临床价值[J]. 临床急诊杂志, 2017, 18(4):256-259.
|
[8] |
侯晓敏. 血清降钙素原和C反应蛋白联合检测对老年人急性胆管炎严重程度的评估价值[J]. 同济大学学报(医学版), 2018, 39(2):112-116, 122.
|
[9] |
钱海超, 芦照青, 张天鹏. 血浆降钙素原与D-二聚体水平在判断急性胆管炎病情严重程度中的临床价值[J]. 临床和实验医学杂志, 2019, 18(18):1949-1952.
|
[10] |
程红英. 不同病情程度肝胆管结石伴急性胆管炎患者血清PCT、CRP水平变化及动态检测临床意义[J]. 哈尔滨医药, 2021, 41(1):99-100.
|
[11] |
邓世波. 血清降钙素原在急性胆管炎严重程度分级中的价值[D]. 延安: 延安大学, 2021.
|
[12] |
郑丽雄. 不同血清学指标对急性胆管炎患者病情评估及预后判断应用价值的研究[D]. 福州: 福建医科大学, 2021.
|
[13] |
Deng X, Wang JW, Wu Q, et al. Lipocalin2 as a useful biomarker for risk stratification in patients with acute cholangitis: a single-center prospective and observational study[J]. Clin Chim Acta, 2022(533):22-30.
|
[14] |
An Z, Braseth AL, Sahar N. Acute cholangitis: causes, diagnosis, and management[J]. Gastroenterol Clin North Am, 2021, 50(2):403-414.
|
[15] |
Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1):31-40.
|
[16] |
Thomas-Rüddel DO, Poidinger B, Kott M, et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia[J]. Crit Care, 2018, 22(1):128.
|
[17] |
Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use[J]. Clin Chem Lab Med, 2019, 57(9):1308-1318.
|
[18] |
Eklund CM. Proinflammatory cytokines in CRP baseline regulation[J]. Adv Clin Chem, 2009(48):111-136.
|
[19] |
George EL, Panos A. Does a high WBC count signal infection?[J]. Nursing, 2005, 35(1):20-21.
|
[20] |
Su R, Zhu J, Wu S, et al. Prognostic significance of platelet (PLT) and platelet to mean platelet volume (PLT/MPV) ratio during apatinib second-line or late-line treatment in advanced esophageal squamous cell carcinoma patients[J]. Technol Cancer Res Treat, 2022(21):153303382110729.
|